Description
Division 1A of Part C of the Regulations applies to COVID-19 drugs. A person must hold a drug establishment licence (DEL) authorizing any activities conducted with respect to COVID-19 drugs.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Drug establishment licences and good manufacturing practices | HTML | Open resource | |
| Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Drug establishment licences and good manufacturing practices | HTML | Open resource |